+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Medical Tourism Market by Treatment Type: Global Opportunity Analysis and Industry Forecast, 2019-2027

  • PDF Icon

    Report

  • 284 Pages
  • November 2020
  • Region: Global
  • Allied Market Research
  • ID: 5237513

The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to 2027.

Medical tourism can be defined as an organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers’ home country. Medical tourists travel across international borders for the maintenance, enhancement, or restoration of their health through affordable healthcare facilities & treatments available in other countries, which are comparatively expensive in their own country. Medical tourists travel to receive medical treatments such as dental treatment, neurological treatment, and cardiovascular treatment.

The growth of the global medical tourism market is majorly driven by affordability and accessibility of quality healthcare services along with assistance from tourism departments and local governments. In addition, the availability of the latest medical technologies in medical tourism hubs across the globe is expected to fuel market growth. However, lengthy, partial reimbursement by payers and difficulties associated with travel, language barriers, availability of documentation, and VISA approval issues act as key restraints of the global market. Conversely, a wider hospital network under insurance coverage for cashless transactions is expected to serve as a remunerative opportunity for the expansion of the global medical tourism market during the period.

The report segments the market into treatment type and region. On the basis of treatment type, the market is segregated into dental treatment, cosmetic treatment, cardiovascular treatment, orthopedic treatment, neurological treatment, cancer treatment, fertility treatment, and others. Region wise, the medical tourism market is studied across North America, Europe, Asia-Pacific, and LAMEA.

The report provides extensive competitive analysis and profiles of key market players such as Aditya Birla Memorial Hospital, Apollo Hospitals Enterprise Limited, Asian Heart Institute, Barbados Fertility Center, Fortis Healthcare Limited, KPJ Healthcare Berhad, NTT Medical Center Tokyo, Prince Court Medical Centre, Samitivej PCL, Seoul National University Hospital, and Wooridul Spine Hospital.

KEY BENEFITS FOR STAKEHOLDERS


  • This report entails a detailed quantitative analysis of the current market trends from 2019 to 2027 to identify the prevailing opportunities.
  • Medical tourism market size and estimations are based on a comprehensive analysis of the key developments in the industry.
  • In-depth analysis based on region assists to understand the regional market and the strategic business planning.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

Key Market Segments

By Treatment Type


  • Dental Treatment
  • Cosmetic Treatment
  • Cardiovascular Treatment
  • Orthopedic Treatment
  • Neurological Treatment
  • Cancer Treatment
  • Fertility Treatment
  • Other Treatments

By Region


  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • India
  • China
  • Indonesia
  • Singapore
  • Malaysia
  • Thailand
  • South Korea
  • Taiwan
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Venezuela
  • Costa Rica
  • UAE
  • South Africa
  • Rest of LAMEA

List of key players profiled in the report


  • Aditya Birla Memorial Hospital
  • Apollo Hospitals Enterprise Limited
  • Asian Heart Institute
  • Barbados Fertility Center
  • Fortis Healthcare Limited
  • KPJ Healthcare Berhad
  • NTT Medical Center Tokyo
  • Prince Court Medical Centre
  • Samitivej PCL
  • Seoul National University Hospital
  • Wooridul Spine Hospital

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)


  • Max Healthcare
  • Mount Elizabeth Hospitals
  • Narayana Health

Table of Contents

Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.3.1. List of Key Players Profiled in the Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models
Chapter 2: Executive Summary
2.1. Key Findings of the Study
2.2. CXO Perspective
Chapter 3: Market Overview
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.3. Reimbursement Scenario
3.3.1. Developed Regions
3.3.2. Developing Regions
3.4. Government Regulations
3.5. Top Player Positioning, 2019
3.6. Porters Five Forces Analysis
3.7. Market Dynamics
3.7.1. Drivers
3.7.1.1. Affordable Good Quality Care
3.7.1.2. Availability of Quality Care
3.7.1.3. Accessible Information and Care
3.7.1.4. Assistance and Support from Government Agencies and Associations
3.7.2. Restraints
3.7.2.1. Limited Coverage and Lengthy Partial Reimbursement by Payers
3.7.2.2. Difficulties Associated With Travel, Language Barriers, Availability, Documentation, and Visa Approval Issues
3.7.3. Opportunities
3.7.3.1. Overseas Promotional Offices Are a Key Source of Medical Tourists
3.7.3.2. Wider Hospital Network Under Insurance Coverage for Cashless Transactions
3.7.4. Impact Analyses
3.8. Impact Analysis of Covid-19 on the Medical Tourism Market
Chapter 4: Medical Tourism Market, by Treatment Type
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Dental Treatment
4.2.1. Key Market Trends, Growth Factors, and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.2.1. Market Size and Forecast, by North America
4.2.2.2. Market Size and Forecast, by Europe
4.2.2.3. Market Size and Forecast, by Asia-Pacific
4.2.2.4. Market Size and Forecast, by LAMEA
4.3. Cosmetic Treatment
4.3.1. Key Market Trends, Growth Factors, and Opportunities
4.3.2. Market Size and Forecast, by Region
4.3.2.1. Market Size and Forecast, by North America
4.3.2.2. Market Size and Forecast, by Europe
4.3.2.3. Market Size and Forecast, by Asia-Pacific
4.3.2.4. Market Size and Forecast, by LAMEA
4.4. Cardiovascular Treatment
4.4.1. Key Market Trends, Growth Factors, and Opportunities
4.4.2. Market Size and Forecast, by Region
4.4.2.1. Market Size and Forecast, by North America
4.4.2.2. Market Size and Forecast, by Europe
4.4.2.3. Market Size and Forecast, by Asia-Pacific
4.4.2.4. Market Size and Forecast, by LAMEA
4.5. Orthopedic Treatment
4.5.1. Key Market Trends, Growth Factors, and Opportunities
4.5.2. Market Size and Forecast, by Region
4.5.2.1. Market Size and Forecast, by North America
4.5.2.2. Market Size and Forecast, by Europe
4.5.2.3. Market Size and Forecast, by Asia-Pacific
4.5.2.4. Market Size and Forecast, by LAMEA
4.6. Neurological Treatment
4.6.1. Key Market Trends, Growth Factors, and Opportunities
4.6.2. Market Size and Forecast, by Region
4.6.2.1. Market Size and Forecast, by North America
4.6.2.2. Market Size and Forecast, by Europe
4.6.2.3. Market Size and Forecast, by Asia-Pacific
4.6.2.4. Market Size and Forecast, by LAMEA
4.7. Cancer Treatment
4.7.1. Key Market Trends, Growth Factors, and Opportunities
4.7.2. Market Size and Forecast, by Region
4.7.2.1. Market Size and Forecast, by North America
4.7.2.2. Market Size and Forecast, by Europe
4.7.2.3. Market Size and Forecast, by Asia-Pacific
4.7.2.4. Market Size and Forecast, by LAMEA
4.8. Fertility Treatment
4.8.1. Key Market Trends, Growth Factors, and Opportunities
4.8.2. Market Size and Forecast, by Region
4.8.2.1. Market Size and Forecast, by North America
4.8.2.2. Market Size and Forecast, by Europe
4.8.2.3. Market Size and Forecast, by Asia-Pacific
4.8.2.4. Market Size and Forecast, by LAMEA
4.9. Other Treatments
4.9.1. Key Market Trends, Growth Factors, and Opportunities
4.9.2. Market Size and Forecast, by Region
4.9.2.1. Market Size and Forecast, by North America
4.9.2.2. Market Size and Forecast, by Europe
4.9.2.3. Market Size and Forecast, by Asia-Pacific
4.9.2.4. Market Size and Forecast, by LAMEA
Chapter 5: Medical Tourism Market, by Region
5.1. Overview
5.1.1. Market Size and Forecast
5.2. North America
5.2.1. Key Market Trends, Growth Factors, and Opportunities
5.2.2. Market Size and Forecast, by Country
5.2.3. Market Size and Forecast, by Treatment Type
5.2.3.1. U.S. Market Size and Forecast
5.2.3.1.1. U.S. Medical Tourism Market, 2019-2027 ($Million)
5.2.3.1.2. Market Size and Forecast, by Treatment Type
5.2.3.2. Canada Market Size and Forecast
5.2.3.2.1. Market Size and Forecast, by Treatment Type
5.2.3.3. Mexico Market Size and Forecast
5.2.3.3.1. Market Size and Forecast, by Treatment Type
5.3. Europe
5.3.1. Key Market Trends, Growth Factors, and Opportunities
5.3.2. Market Size and Forecast, by Country
5.3.3. Market Size and Forecast, by Treatment Type
5.3.3.1. Germany Market Size and Forecast
5.3.3.1.1. Market Size and Forecast, by Treatment Type
5.3.3.2. France Market Size and Forecast
5.3.3.2.1. Market Size and Forecast, by Treatment Type
5.3.3.3. UK Market Size and Forecast
5.3.3.3.1. Market Size and Forecast, by Treatment Type
5.3.3.4. Italy Market Size and Forecast
5.3.3.4.1. Market Size and Forecast, by Treatment Type
5.3.3.5. Spain Market Size and Forecast
5.3.3.5.1. Market Size and Forecast, by Treatment Type
5.3.3.6. Rest of Europe Market Size and Forecast
5.3.3.6.1. Market Size and Forecast, by Treatment Type
5.4. Asia-Pacific
5.4.1. Key Market Trends, Growth Factors, and Opportunities
5.4.2. Market Size and Forecast, by Country
5.4.3. Market Size and Forecast, by Treatment Type
5.4.3.1. India Market Size and Forecast
5.4.3.1.1. Market Size and Forecast, by Treatment Type
5.4.3.2. China Market Size and Forecast
5.4.3.2.1. Market Size and Forecast, by Treatment Type
5.4.3.3. Indonesia Market Size and Forecast
5.4.3.3.1. Market Size and Forecast, by Treatment Type
5.4.3.4. Singapore Market Size and Forecast
5.4.3.4.1. Market Size and Forecast, by Treatment Type
5.4.3.5. Malaysia Market Size and Forecast
5.4.3.5.1. Market Size and Forecast, by Treatment Type
5.4.3.6. Thailand Market Size and Forecast
5.4.3.6.1. Market Size and Forecast, by Treatment Type
5.4.3.7. South Korea Market Size and Forecast
5.4.3.7.1. Market Size and Forecast, by Treatment Type
5.4.3.8. Taiwan Market Size and Forecast
5.4.3.8.1. Market Size and Forecast, by Treatment Type
5.4.3.9. Rest of Asia-Pacific Market Size and Forecast
5.4.3.9.1. Market Size and Forecast, by Treatment Type
5.5. LAMEA
5.5.1. Key Market Trends, Growth Factors, and Opportunities
5.5.2. Market Size and Forecast, by Country
5.5.3. Market Size and Forecast, by Treatment Type
5.5.3.1. Brazil Market Size and Forecast
5.5.3.1.1. Market Size and Forecast, by Treatment Type
5.5.3.2. Venezuela Market Size and Forecast
5.5.3.2.1. Market Size and Forecast, by Treatment Type
5.5.3.3. Costa Rica Market Size and Forecast
5.5.3.3.1. Market Size and Forecast, by Treatment Type
5.5.3.4. Uae Market Size and Forecast
5.5.3.4.1. Market Size and Forecast, by Treatment Type
5.5.3.5. South Africa Market Size and Forecast
5.5.3.5.1. Market Size and Forecast, by Treatment Type
5.5.3.6. Rest of LAMEA Market Size and Forecast
5.5.3.6.1. Market Size and Forecast, by Treatment Type
Chapter 6: Company Profile
6.1. Apollo Hospitals Enterprise Limited
6.1.1. Company Overview
6.1.2. Company Snapshot
6.1.3. Operating Business Segments
6.1.4. Product Portfolio
6.1.5. Business Performance
6.1.6. Key Strategic Moves and Developments
6.2. Fortis Healthcare Limited
6.2.1. Company Overview
6.2.2. Company Snapshot
6.2.3. Operating Business Segments
6.2.4. Product Portfolio
6.2.5. Business Performance
6.3. Asian Heart Institute
6.3.1. Company Overview
6.3.2. Company Snapshot
6.3.3. Operating Business Segments
6.3.4. Product Portfolio
6.4. Kpj Healthcare Berhad
6.4.1. Company Overview
6.4.2. Company Snapshot
6.4.3. Operating Business Segments
6.4.4. Product Portfolio
6.4.5. Business Performance
6.5. Ntt Medical Center Tokyo
6.5.1. Company Overview
6.5.2. Company Snapshot
6.5.3. Operating Business Segments
6.6. Seoul National University Hospital.
6.6.1. Company Overview
6.6.2. Company Snapshot
6.6.3. Operating Business Segments
6.6.4. Product Portfolio
6.7. Uz Leuven
6.7.1. Company Overview
6.7.2. Company Snapshot
6.7.3. Operating Business Segments
6.7.4. Product Portfolio
6.8. Wooridul Spine Hospital
6.8.1. Company Overview
6.8.2. Company Snapshot
6.8.3. Product Portfolio
6.9. Aditya Birla Memorial Hospital
6.9.1. Company Overview
6.9.2. Company Snapshot
6.9.3. Operating Business Segments
6.9.4. Product Portfolio
6.10. Barbados Fertility Center
6.10.1. Company Overview
6.10.2. Company Snapshot
6.10.3. Operating Business Segments
6.10.4. Product Portfolio
6.11. Prince Court Medical Centre
6.11.1. Company Overview
6.11.2. Company Snapshot
6.11.3. Operating Business Segments
6.11.4. Product Portfolio
6.12. Samitivej Pcl.
6.12.1. Company Overview
6.12.2. Company Snapshot
6.12.3. Operating Business Segments
6.12.4. Product Portfolio

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...